More bad news for mesothelioma victims: A drug trial involving Bayer’s antibody-drug conjugate (ADC), otherwise known as anetumab ravtansine, has failed.
According to a press release issued by MorphoSys AG, one of Bayer’s partners, phase II of this trial missed its “primary endpoint in patients with advanced pleural mesothelioma” — meaning the drug failed to improve progression-free survival in mesothelioma patients.
Dr. Markus Enzelberger, Interim Chief Scientific Officer of MorphoSys AG, was quoted as saying, “The outcome of this phase […] is disappointing, in particular for the patients suffering from this serious and extremely difficult to treat disease.”
Despite this setback, however, Bayer has said it remains committed to anetumab ravtansine, and will continue to evaluate the drug’s potential for treating other types of tumor/cancers.
Even though there is no treatment, legal options may be available
This recent drug trial failure certainly comes as bad news to the countless mesothelioma victims who suffer from a disease with no known cure — although there are several treatment options still being tested.
However, while there is no cure for mesothelioma, there may be legal options available. For instance, since the primary cause of mesothelioma is asbestos exposure, victims may be able to seek compensation from the company that manufactured the asbestos-containing product — or from one of the bankruptcy trusts set up to handle these claims.
But, you may need to act fast since the clock on the statute of limitations starts to tick as soon as you are diagnosed, and once it expired, you may not be able to bring a claim.